Viatris (VTRS) Change in Account Payables (2020 - 2026)
Viatris (VTRS) posted Change in Account Payables of -$21.2 million for Q2 2026, down 164.83% on a QoQ basis from $32.7 million in Q1 2026, and up 92.72% year-over-year from -$11.0 million in Q2 2025.
Analysis
Viatris (VTRS) Change in Account Payables (2020 - 2026) Analysis & Trends
Viatris has reported Change in Account Payables for 7 years, with the latest figure at -$21.2 million in Q2 2026.
- On a quarterly basis, Change in Account Payables rose 92.72% year-over-year to -$21.2 million in Q2 2026; TTM through Jun 2026 was $33.2 million, a 115.81% increase from a year earlier, with the FY2025 full-year figure at -$168.0 million, down 566.67% from the prior year.
- Change in Account Payables was -$21.2 million for Q2 2026 at Viatris, down from $32.7 million in the prior quarter.
- The five-year high for Change in Account Payables was $287.9 million in Q1 2024, with the low at -$329.9 million in Q3 2022.
- Average Change in Account Payables over 5 years is $20.2 million, with a median of $25.6 million recorded in 2025.
- The sharpest annual moves came in 2023 and 2024: Change in Account Payables jumped 707.28% in 2023, then sank 2590.32% in 2024.
- Over 5 years, Change in Account Payables stood at $245.6 million in 2022, then slumped by 68.08% to $78.4 million in 2023, then plunged by 41.71% to $45.7 million in 2024, then plunged by 59.52% to $18.5 million in 2025, then slumped by 214.59% to -$21.2 million in 2026.
- The last three Change in Account Payables figures came in at -$21.2 million (Q2 2026), $32.7 million (Q1 2026), and $18.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.53 Bn | 38.88 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn | -21.20 Mn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 45.25 Mn |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.33 Bn | 334.51 Mn | -8.53 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | 30.70 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | -1.12 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 400.20 Mn | 358.95 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.20 Mn |
| Mar 31, 2026 | 32.70 Mn |
| Dec 31, 2025 | 18.50 Mn |
| Sep 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | -291.30 Mn |
| Mar 31, 2025 | 101.60 Mn |
| Dec 31, 2024 | 45.70 Mn |
| Sep 30, 2024 | -66.00 Mn |
| Jun 30, 2024 | -231.60 Mn |
| Mar 31, 2024 | 287.90 Mn |
| Dec 31, 2023 | 78.40 Mn |
| Sep 30, 2023 | 43.60 Mn |
| Jun 30, 2023 | 9.30 Mn |
| Mar 31, 2023 | 183.40 Mn |
| Dec 31, 2022 | 245.60 Mn |
| Sep 30, 2022 | -329.90 Mn |
| Jun 30, 2022 | 284.70 Mn |
| Mar 31, 2022 | -30.20 Mn |
| Dec 31, 2021 | 38.00 Mn |
| Sep 30, 2021 | -54.90 Mn |